The level of NT-proBNP on the 7th day after birth (±2 days) can be used as a valuable early biomarker for predicting moderate and severe BPD/death, and the established nomogram can help clinicians predict the risk effectively and easily. Here, NPPB is linked to bronchopulmonary dysplasia.